Tranche Update on Dongwha Pharm.Co.,Ltd's Equity Buyback Plan announced on July 20, 2017.
September 24, 2017
Share
From July 20, 2017 to September 21, 2017, the company has repurchased 100,000 shares, representing 0.36% for KRW 875.76 million. With this, the company has completed the repurchase of 100,000 shares, representing 0.36% for KRW 875.76 million under the buyback announced on July 20, 2017.
DONGWHA PHARM.CO., LTD is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products consist of ethical drugs, including digestive system remedies, antibiotics, cardiovascular and metabolic disease treatments, non steroidal anti-inflammatory drugs, respiratory remedies, muscle relaxants, nervous system remedies, dermatological remedies and urinary system remedies, and over-the-counter (OTC) drugs, including cold remedies, dental remedies, dermatological remedies, hepatic protectors, nutrients, tonics, topical analgesics, anti-smoking agents and others. It also provides medicine raw materials, health food and drinks, as well as cosmetics. The Company distributes its products within domestic market and to overseas markets.
DONGWHA PHARM.CO.,LTD 
